Incidence and prevalence of multiple sclerosis in Europe: A systematic review

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Kingwell, Elaine ^a   Marriott, James J ^b   Jetté, Nathalie ^c,d   Pringsheim, Tamara ^c,d,e   Makhani, Naila ^f   Morrow, Sarah A ^g   Fisk, John D ^c,h   Evans, Charity ⁱ   Béland, Sarah G ^j   Kulaga, Sophie ^j   Dykeman, Jonathan ^c   Wolfson, Christina ^k   Koch, Marcus W ^c,d   Marrie, Ruth A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF SASKATCHEWAN   (Canada)

^j RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^k MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Epidemiology; Europe; Incidence; Multiple sclerosis; Prevalence

Indexed keywords

ARTICLE; DEMOGRAPHY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; EUROPE; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; INCIDENCE; LIFE EXPECTANCY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION; PREVALENCE; SCORING SYSTEM; SEX DIFFERENCE; SEX RATIO; SYMPTOM; SYSTEMATIC REVIEW;

DATABASES, FACTUAL; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MULTIPLE SCLEROSIS; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84884581173     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-128     Document Type: Article

References (150)

1. World Health Organization Atlas multiple sclerosis resources in the world 2008 2008, Geneva: WHO Press, World Health Organization.
2. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology 2007, 29(3-4):150-155.
3. Ebers GC. Environmental factors and multiple sclerosis. The Lancet Neurology 2008, 7(3):268-277.
4. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010, 9:520-532. 10.1016/S1474-4422(10)70064-8, 20398859.
5. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008, 71(2):129-135. 10.1212/01.wnl.0000316802.35974.34, 18606967.
6. Orton S-M, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5:932-936. 10.1016/S1474-4422(06)70581-6, 17052660.
7. Ramagopalan SV, Byrnes JK, Orton SM, Dyment DA, Guimond C, Yee IM, Ebers GC, Sadovnick AD. Sex ratio of multiple sclerosis and clinical phenotype. Eur J Neurol 2010, 17(4):634-637. 10.1111/j.1468-1331.2009.02850.x, 19968710.
8. Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson SJ, Lepore V, Grand'maison F, Duquette P, Izquierdo G, Grammond P, et al. Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One 2012, 7(10):348078.
9. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol 2000, 6(Suppl 2):S134-S140.
10. Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, Koch M, Makhani N, Morrow S, Fisk J, et al. Incidence and Prevalence of Multiple Sclerosis in the Americas: a systematic review. Neuroepidemiology 2013, 40(3):195-210. 10.1159/000342779, 23363936.
11. Becus{comma below} T, Popoviciu L. Epidemiologic survey of multiple sclerosis in Mures{comma below} County, Romania. Rom J Neurol Psychiat 1994, 32(2):115-122.
12. Garcia JR, Rodriguez S, Sosa Henriquez M, Batista E, Corujo E, Font De Mora Turon A, Hernandez Hernandez D, Betancor Leon P. Prevalence of multiple sclerosis in Lanzarote (Canary Islands). Neurology 1989, 39:265-267. 10.1212/WNL.39.2.265, 2915799.
13. Grasso AA, Regio A, Marano P, Florio S, Scordino N, Cappello S, Nicoletti F. Epidemiological survey of multiple sclerosis in Catania city. Ital J Neurol Sci 1992, 13:301-309. 10.1007/BF02223094, 1601629.
14. Matias-Guiu J, Bolumar F, Martin R, Insa R, Casquero P, Moltó JM, Calatayud EJA. Multiple sclerosis in Spain: an epidemiological study of the Alcoy health region, Valencia. Acta Neurol Scand 1990, 6:479-493.
15. Dean G, Elian M, Galea De Bono A, Pace Asciak R, Vella N, Mifsud V, Aquilina J. Multiple sclerosis in Malta in 1999: an update. J Neurol Neurosurg Psychiatry 2002, 73:256-260. 10.1136/jnnp.73.3.256, 1738011, 12185155.
16. Milanov I, Topalov N, Kmetska T. Prevalence of Multiple Sclerosis in Gypsies and Bulgarians. Neuroepidemiology 1999, 18:218-222. 10.1159/000026214, 10364723.
17. Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008, 255(1):49-55. 10.1007/s00415-007-0659-8, 18080855.
18. Binzer M, Forsgren L, Holmgren G, Drugge U, Fredrikson S. Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994, 57:497-499. 10.1136/jnnp.57.4.497, 1072883, 8164003.
19. Tienari PJ, Sumelahti ML, Rantamaki T, Wikstrom J. Multiple sclerosis in western Finland: evidence for a founder effect. Clin neurol neurosur 2004, 106(3):175-179.
20. Nicoletti A, Lo Fermo S, Reggio E, Tarantello R, Liberto A, Le Pira F, Patti F, Reggio A. A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily. J Neurol 2005, 252(8):921-925. 10.1007/s00415-005-0781-4, 15789132.
21. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998, 64:730-735. 10.1136/jnnp.64.6.730, 2170112, 9647300.
22. Sumelahti ML, Tienari PJ, Wikström J, Palo J, Hakama M. Regional and Temporal Variation in the Incidence of Multiple Sclerosis in Finland 1979-1993. Neuroepidemiology 2000, 19:67-75. 10.1159/000026241, 10686531.
23. Dean G, Aksoy H, Akalin T, Middleton L, Kyriallis K. Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus: a United Nations (UNHCR) Bicommunal Project. J Neurol Sci 1997, 145:163-168. 10.1016/S0022-510X(96)00255-9, 9094044.
24. Middleton L, Dean G. Multiple sclerosis in Cyprus. J Neurol Sci 1991, 103:29-36. 10.1016/0022-510X(91)90279-G, 1865229.
25. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13(3):227-231. 10.1002/ana.410130302, 6847134.
26. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
27. Rose AS, Ellison GW, Myers LW, Tourtellotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976, 26:20-22. 10.1212/WNL.26.6_Part_2.20, 58393.
28. Schumaker GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965, 122:552-568.
29. McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal 1972, Edinburgh: Churchill Livingstone.
30. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977, 33:4-9.
31. Grimaldi LM, Palmeri B, Salemi G, Giglia G, D'Amelio M, Grimaldi R, Vitello G, Ragonese P, Savettieri G. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology 2007, 28(1):28-32. 10.1159/000097853, 17164567.
32. Grimaldi LME, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology 2001, 57:1891-1893. 10.1212/WNL.57.10.1891, 11723283.
33. Nicoletti A, Lo Bartolo ML, Lo Fermo S, Cocuzza V, Panetta MR, Marletta C, Ciancio MR, Cataldi ML, Patti F, Reggio A. Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology 2001, 56:62-66. 10.1212/WNL.56.1.62, 11148237.
34. Nicoletti A, Patti F, Lo Fermo S, Sorbello V, Reggio E, Maimone D, Zappia M, Reggio A. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005, 65:1259-1263. 10.1212/01.wnl.0000180628.38786.85, 16247054.
35. Ragonese P, Salemi G, D'Amelio M, Gammino M, Aridon P, Savettieri G. Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study. Neuroepidemiology 2004, 23(6):306-309. 10.1159/000080097, 15297798.
36. Salemi G, Ragonese P, Aridon P, Scola G, Saporito V, Conte S, Savettieri G. Incidence of multiple sclerosis in Bagheria City, Sicily, Italy. Neurol Sci 2000, 21:361-365. 10.1007/s100720070051, 11441573.
37. Savettieri G, Salemi G, Ragonese P, Aridon P, Scola G, Randisi G. Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy. J Neurol 1998, 245:40-43.
38. Bergamaschi R, Montomoli C, Candeloro E, Monti MC, Cioccale R, Bernardinelli L, Fratino P, Cosi V, Group P. Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy. J Neurol Sci 2006, 244(1-2):127-131.
39. Granieri E, Economou NT, De Gennaro R, Tola MR, Caniatti L, Govoni V, Fainardi E, Casetta I. Multiple sclerosis in the province of Ferrara: evidence for an increasing trend. J Neurol 2007, 254(12):1642-1648. 10.1007/s00415-007-0560-5, 18008026.
40. Granieri E, Malagu S, Casetta I, Tola MR, Govoni V, Paolino E, Monetti VC. Multiple sclerosis in Italy: a reappraisal of incidence and prevalence in Ferrara. Arch Neurol 1996, 53:793-798. 10.1001/archneur.1996.00550080115019, 8759986.
41. Guidetti D, Cavalletti S, Merelli E, Zanoni P, Simonazzi P, Sola P, Solime F. Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena, Italy. Neuroepidemiology 1995, 14:7-13. 10.1159/000109772, 7898604.
42. Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Ermani M, Davetag F, De L, Garbin E, Verdelli F, et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Multiple sclerosis 2003, 9(4):387-392. 10.1191/1352458503ms920oa, 12926844.
43. Sironi L, Mamoli A, D'Alessandro G, Camerlingo M, Bottacchi E. Frequency of multiple sclerosis in Valle d'Aosta, 1971-1985. Neuroepidemiology 1991, 10:66-69. 10.1159/000110249, 2062420.
44. Solaro C, Allemani C, Messmer Uccelli M, Canevari E, Dagnino N, Pizio R, Regesta G, Tanganelli P, Battaglia MA, Mancardi GL. The prevalence of multiple sclerosis in the north-west Italian province of Genoa. J Neurol 2005, 252(4):436-440. 10.1007/s00415-005-0670-x, 15726261.
45. Casetta I, Granieri E, Marchi D, Murgia SB, Tola MR, Ticca A, Lauria G, Govoni V, Murgia B, Pugliatti M. An epidemiological study of multiple sclerosis in central Sardinia, Italy. Acta Neurol Scand 1998, 98:391-394. 10.1111/j.1600-0404.1998.tb07319.x, 9875616.
46. Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB, Ticca A, Pugliatti M, Murgia B, Rosati G. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000, 55:842-847. 10.1212/WNL.55.6.842, 10994006.
47. Montomolia C, Allemania C, Solinasa G, Mottaa G, Bernardinellia L, Clementeb S, Murgiac BS, Ticcac AF, Musuc L, Pirasc ML, et al. An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia, Italy. Neuroepidemiology 2002, 21:187-193. 10.1159/000059522, 12065881.
48. Pugliatti M, Riise T, Sotgiu MA, Sotgiu S, Satta WM, Mannu L, Sanna G, Rosati G. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 2005, 25(3):129-134. 10.1159/000086677, 15990443.
49. Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Pirastru M, Murgia B, Mannu L, Sanna G, Rosati G. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001, 103:20-26. 10.1034/j.1600-0404.2001.00207.x, 11153884.
50. Rosati G, Aiello I, Mannu L, Pirastru MI, Agnetti V, Sau G, Garau M, Gioia R, Sanna G. Incidence of multiple sclerosis in the town of Sassari, Sardinia, 1965 to 1985: evidence for increasing occurrence of the disease. Neurology 1988, 38:384-388. 10.1212/WNL.38.3.384, 3347341.
51. Rosati G, Aiello I, Pirastru MI, Mannu L, Sanna G, Sau GF, Sotgiu S. Epidemiology of multiple sclerosis in northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996, 15:10-19. 10.1159/000109884, 8719044.
52. Millefiorini E, Cortese A, Di Rezze S, Barletta G, Bellantonio P, Batocchi AP, Di Battista G, Fiore S, Gasperini C, Grasso MG, et al. The prevalence of multiple sclerosis in central Italy. Multiple sclerosis 2010, 16(12):1432-1436. 10.1177/1352458510373263, 20834041.
53. Totaro R, Marini C, Cialfi A, Giunta M, Carolei A. Prevalence of multiple sclerosis in the L'Aquila district, central Italy. J Neurol Neurosurg Psychiatry 2000, 68:349-352. 10.1136/jnnp.68.3.349, 1736830, 10675219.
54. Iuliano G, Napoletano R. Prevalence and incidence of multiple sclerosis in Salerno (southern Italy) and its province. Eur J Neurol 2008, 15(1):73-76.
55. Granieri E, Monaldini C, De Gennaro R, Guttmann S, Volpini M, Stumpo M, Fazio P, Casetta I. Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study. Multiple sclerosis 2008, 14(3):325-329. 10.1177/1352458507084114, 18208882.
56. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Castiglia P, Solinas G, Dolei A, Serra C, Bonetti B, Rosati G. Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy. Eur J Neurol 2002, 9:329-341. 10.1046/j.1468-1331.2002.00412.x, 12099914.
57. Allen KW. The prevalence of multiple sclerosis in the health district of Bassetlaw. Public Heal 1990, 104:37-43.
58. Ford HL, Gerry E, Airey CM, Vail A, Johnson MH, Williams DRR. The prevalence of multiple sclerosis in the Leeds Health Authority. J Neurol Neurosurg Psychiatry 1998, 64:605-610. 10.1136/jnnp.64.5.605, 2170076, 9598675.
59. Ford HL, Gerry E, Johnson M, Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 2002, 249:260-265. 10.1007/s004150200002, 11993523.
60. Fox CM, Bensa S, Bray I, Zajicek JP. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004, 75:56-60. 1757455, 14707308.
61. Lockyer MJ. Prevalence of multiple sclerosis in five rural Suffolk practices. BMJ 1991, 303:347-348. 10.1136/bmj.303.6798.347, 1670776, 1912778.
62. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000, 123:665-676. 10.1093/brain/123.4.665, 10733998.
63. Mumford CJ, Fraser MB, Wood NW, Compston DAS. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992, 55:877-882. 10.1136/jnnp.55.10.877, 1015180, 1431950.
64. Roberts MHW, Martin JP, McLellan DL, McIntosh-Michaelis SA, Spackman AJ. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1991, 54:55-59. 10.1136/jnnp.54.1.55, 1014300, 2010761.
65. Robertson N, Deans J, Fraser M, Compston DAS. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995, 59:71-76. 10.1136/jnnp.59.1.71, 1073604, 7608713.
66. Robertson N, Deans J, Fraser M, Compston DAS. Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register. J Epidemiol Community Health 1996, 50:274-279. 10.1136/jech.50.3.274, 1060283, 8935458.
67. Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996, 61:415-417. 10.1136/jnnp.61.4.415, 486587, 8890784.
68. Williams ES, McKeran RO. Prevalence Of Multiple Sclerosis In A South London Borough. BMJ 1986, 293(6541):237-239. 10.1136/bmj.293.6541.237, 1341173, 3089468.
69. Rice-Oxley M, Williams ES, Rees JE. A prevalence survey of multiples clerosis in Sussex. J Neurol Neurosurg Psychiatry 1995, 58:27-30. 10.1136/jnnp.58.1.27, 1073264, 7823063.
70. Cook SD, MacDonald J, Tapp W, Poskanzer D, Dowling PC. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand 1988, 77:148-151. 10.1111/j.1600-0404.1988.tb05885.x, 3259061.
71. Donnan PT, Parratt JDE, Wilson SV, Forbes RB, O'Riordan JI, Swingler RJ. Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic. Multiple sclerosis 2005, 11(4):403-408. 10.1191/1352458505ms1191oa, 16042222.
72. Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?. J Neurol 1999, 246:1033-1040. 10.1007/s004150050509, 10631635.
73. Grant RM, Carver AD, Sloan RL. Multiple sclerosis in Fife. Scot Med J 1998, 42:44-47.
74. Murray S, Bashir K, Penrise G, Womersley SJ. Epidemiology of multiple sclerosis in Glasgow. Scot Med J 2004, 49:100-104.
75. Hennessy A, Swingler RJ, Compston DAS. The incidence and mortality of multiple sclerosis in southeast Wales. J Neurol Neurosurg Psychiatry 1989, 52:1085-1089. 10.1136/jnnp.52.9.1085, 1031745, 2795079.
76. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009, 80(4):386-391.
77. Swingler RJ, Compston DAS. The prevalence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 1988, 51:1520-1524. 10.1136/jnnp.51.12.1520, 1032767, 3265431.
78. Gray OM, McDonnell GV, Hawkins SA. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Multiple sclerosis 2008, 14(7):880-886. 10.1177/1352458508090663, 18573832.
79. Hawkins SA, Kee K. The changing prevalence of multiple sclerosis in Northern Ireland with reference to benign multiple sclerosis. Recent advances in multiple sclerosis therapy: proceedings of the Vth Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Brussels, 16-18 March 1989 1989, 357-358. Amsterdam: Excerpta Medica, Gonsette RE, Delmotte P.
80. McDonnell GV, Hawkins SA. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998, 50:423-428. 10.1212/WNL.50.2.423, 9484366.
81. McGuigan C. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry 2004, 75(4):572-576. 10.1136/jnnp.2003.012666, 1739004, 15026499.
82. Sharpe G, Price SE, Last A, Thompson RJ. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey. J Neurol Neurosurg Psychiatry 1995, 58:22-26. 10.1136/jnnp.58.1.22, 1073263, 7823062.
83. Alonso A, Jick SS, Olek MJ, Hernan MA. Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort. J Neurol 2007, 254(12):1736-1741. 10.1007/s00415-007-0602-z, 17896096.
84. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001, 8:463-469. 10.1046/j.1468-1331.2001.00269.x, 11554910.
85. Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R. Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 2003, 109:378-384.
86. Grønlie SA, Myrvoll E, Hansen G, Grønning M, Mellgren SI. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 2000, 247:129-133. 10.1007/PL00007793, 10751116.
87. Grønning M, Riise T, Kvåle G, Nyland H, Larsen JP, Aarli JA. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. Neuroepidemiology 1991, 10:53-61. 10.1159/000110247, 2062418.
88. Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr K-M. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006, 66:182-186. 10.1212/01.wnl.0000195549.95448.b9, 16434650.
89. Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. Tissue antigens 2007, 69(4):299-304. 10.1111/j.1399-0039.2007.00803.x, 17389012.
90. Midgard R, Riise T, Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991, 41:887-892. 10.1212/WNL.41.6.887, 2046935.
91. Midgard R, Riise T, Svanes C, Kvåle G, Nyland H. Incidence of multiple sclerosis in M0re and Romsdal, Norway from 1950 to 1991: an age-period-cohort analysis. Brain 1996, 119:203-211. 10.1093/brain/119.1.203, 8624682.
92. Sundström P, Nyström L, Forsgren L. Prevalence of multiple sclerosis in Västerbotten County in northern Sweden. Acta Neurol Scand 2001, 103:214-218. 10.1034/j.1600-0404.2001.103004214.x, 11328191.
93. Sundström P, Nyström L, Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 2003, 74:29-32. 10.1136/jnnp.74.1.29, 1738162, 12486262.
94. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990, 82:161-168. 10.1111/j.1600-0404.1990.tb04483.x, 2270743.
95. Bostrom I, Callander M, Kurtzke JF, Landtblom AM. High prevalence of multiple sclerosis in the Swedish county of Varmland. Multiple sclerosis 2009, 15(11):1253-1262. 10.1177/1352458509345909, 19805442.
96. Bentzen J, Flachs EM, Stenager E, Bronnum-Hansen H, Koch-Henriksen N. Prevalence of multiple sclerosis in Denmark 1950-2005. Multiple sclerosis 2010, 16(5):520-525. 10.1177/1352458510364197, 20215479.
97. Eaton WW, Pedersen MG, Atladottir HO, Gregory PE, Rose NR, Mortensen PB. The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res 2010, 47(1-3):228-231. 2892249, 20066507.
98. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007, 29(1):1-9. 10.1016/j.jaut.2007.05.002, 2717015, 17582741.
99. Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Multiple sclerosis 1999, 5(4):293-296.
100. Sarasoja T, Wikstrom J, Paltamaa J, Hakama M, Sumelahti ML. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 2004, 110(5):331-336. 10.1111/j.1600-0404.2004.00326.x, 15476462.
101. Benedikz J, Magnússon H, Guõmundsson G. Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Ann Neurol 1994, 36(S2):S175-S179. 10.1002/ana.410360804, 7998786.
102. Benedikz J, Magnússon H, Poser CM, Benedikz E, Olafsdottir G, Gudmundsson G. Multiple sclerosis in Iceland 1900-1985. J Trop and Geogr Neurol 1991, 1:16-22.
103. Benedikz J, Stefánsson M, Guõmundsson J, Jónasdóttir A, Fossdal R, Gulcher J, Stefánsson K. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study. Clin Neurol Neurosurg 2002, 104:208-210. 10.1016/S0303-8467(02)00040-9, 12127656.
104. Joensen P. Multiple sclerosis incidence in the Faroe Islands 1986-2007. Acta Neurol Scand 2010, 121(5):348-353. 10.1111/j.1600-0404.2009.01252.x, 20015109.
105. De Sa J, Paulos A, Mendes H, Becho J, Marques J, Roxo J. The prevalence of multiple sclerosis in the District of Santarem, Portugal. J Neurol 2006, 253(7):914-918. 10.1007/s00415-006-0132-0, 16502218.
106. Ares B, Prieto JM, Lema M, Dapena D, Arias M, Noya M. Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain). Mult Scler 2007, 13:262-264. 10.1177/1352458506069540, 17439895.
107. Benito-Léon J, Martin E, Vela L, Villar ME, Felgueroso B, Marrero C, Guerrero A, Ruiz-Galiana J. Multiple sclerosis in Mbstoles, central Spain. Acta Neurol Scand 1998, 98:238-242. 10.1111/j.1600-0404.1998.tb07302.x, 9808272.
108. Bufill E, Blesa R, Galan I, Dean G. Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain. J Neurol Neurosurg Psychiatry 1995, 58:577-581. 10.1136/jnnp.58.5.577, 1073488, 7745405.
109. Fernandez O, Fernandez V, Martinez-Cabrera V, Mayorga C, Alonso A, Leon A, Arnal C, Hens M, Luque G, de Ramon E, et al. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 2008, 71(5):426-433. 10.1111/j.1399-0039.2008.01016.x, 18312478.
110. Fernandez O, Luque G, San Román C, Bravo M, Dean G. The prevalence of multiple sclerosis - in the Sanitary District of Vélez-Malaga, southern Spain. Neurology 1994, 44:425-429. 10.1212/WNL.44.3_Part_1.425, 8145909.
111. Modrego Pardo PJ, Pina Latorre MA, López A, Errea JM. Prevalence of multiple sclerosis in the province of Teruel, Spain. J Neurol 1997, 244:182-185. 10.1007/s004150050070, 9050959.
112. Modrego PJ, Pina MA. Trends in prevalence and incidence of multiple sclerosis in Bajo Aragón, Spain. J Neurol Sci 2003, 216(1):89-93. 10.1016/j.jns.2003.07.007, 14607307.
113. Pina MA, Ara JR, Modrego PJ, Morales F, Capablo JL. Prevalence of multiple sclerosis in the sanitary district of Calatayud, Northern Spain: is Spain a zone of high risk for this disease?. Neuroepidemiology 1998, 17:258-264. 10.1159/000026178, 9705585.
114. Tola MA, Yugueros MI, Fernández-Buey N, Fernández-Herranz R. Prevalence of multiple sclerosis in Valladolid, northern Spain. J Neurol 1999, 246:170-174. 10.1007/s004150050329, 10323313.
115. Uria DF, Calatayud MT, Virgala P, Diaz A, Chamizo C, Dean G. Multiple sclerosis in Gijon health district, Asturias, northern Spain. Acta Neurol Scand 1997, 96:375-379.
116. Aladro Y, Alemany MJ, Perez-Vieitez MC, Amela R, Conde M, Reyes MP, Alamo F, Angel-Moreno A. Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain. Neuroepidemiology 2005, 24(1-2):70-75.
117. Hernandez MA. Epidemiology of multiple sclerosis in the Canary Islands (Spain): a study on the island of La Palma. J Neurol 2002, 249(10):1378-1381. 10.1007/s00415-002-0841-y, 12382152.
118. Casqueroa P, Villosladac P, Montalbán X, Torrent M. Frequency of multiple sclerosis in Menorca, Balearic Islands, Spain. Neuroepidemiology 2001, 20:129-133. 10.1159/000054772, 11359081.
119. van Ooteghem P, D'Hooghe MB, Vlietinck R, Carton H. Prevalence of multiple sclerosis in Flanders, Belgium. Neuroepidemiology 1994, 13:220-225. 10.1159/000110383, 7969706.
120. Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Multiple sclerosis 2007, 13(8):962-967. 10.1177/1352458507077938, 17623734.
121. Moreau T, Manceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M. Incidence of multiple sclerosis in Dijon, France: a population-based ascertainment. Neurol Res 2000, 22:156-159.
122. Sagnes-Raffy C, Gourraud P-A, Hannon V, Bourrel R, Laffontan M-A, Gaulene M-C, Viala F, Clanet M. La SEP en Haute-Garonne: une sous-estimation importante du nombre de cas. Rev Epidemiol Sante Publique 2010, 59:23-31.
123. Fromont A, Binquet C, Sauleau EA, Fournel I, Bellisario A, Adnet J, Weill A, Vukusic S, Confavreux C, Debouverie M, et al. Geographic variations of multiple sclerosis in France. Brain 2010, 133(Pt 7):1889-1899.
124. Beer S, Kesselring J. High prevalence of multiple sclerosis in Switzerland. Neuroepidemiology 1994, 13:14-18. 10.1159/000110353, 8190201.
125. Poser S, Stickel B, Krtsch U, Burckhardt D, Nordman B. Increasing incidence of multiple sclerosis in south lower Saxony, Germany. Neuroepidemiology 1989, 8:207-213. 10.1159/000110184, 2755552.
126. Fasbender P, Kolmel HW. Incidence of multiple sclerosis in the urban area of Erfurt, Thuringia, Germany. Neuroepidemiology 2008, 30(3):147-151. 10.1159/000122331, 18382113.
127. Baumhackl U, Eibl G, Ganzinger U, Hartung HP, Mamoli B, Pfeiffer KP, Fazekas F, Vass K, Committee AMS. Prevalence of multiple sclerosis in Austria; results of a nationwide survey. Neuroepidemiology 2002, 21:226-234. 10.1159/000065640, 12207150.
128. Bencsik K, Rajda C, Füvesi J, Klivényi P, Járdánházy T, Török M, Vécsei L. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional Status of patients in Csongrád County, Hungary. Eur Neurol 2001, 46:206-209. 10.1159/000050806, 11721128.
129. Bencsik K, Rajda C, Klivényi P, Járdánházy T, Vécsei L. The prevalence of multiple sclerosis in the Hungarian city of Szeged. Acta Neurol Scand 1998, 97:315-319.
130. Sepcic J, Antonelli L, Materljan E, Sepic-Grahovac D. Multiple sclerosis cluster in Gorski Kotar, Croatia, Yugoslavia. Multiple sclerosis research: proceedings of the International Multiple Sclerosis Conference-an update on Multiple Sclerosis 1989, 165-169. Amsterdam: Excerpta Medica, Battaglia MA.
131. Pekmezovic T, Jarebinski M, Drulovic J, Stojsavljevic N, Levic Z. Prevalence of multiple sclerosis in Belgrade, Yugoslavia. Acta Neurol Scand 2001, 104:353-357. 10.1034/j.1600-0404.2001.00064.x, 11903089.
132. Dobec-Meić B, Puljić I. Incidence of multiple sclerosis in the Varaždin County. Neurol Croat 2007, 56(1-2):17-24.
133. Dobec-Meić B, Puljić I, Kalousek M. Prevalence of multiple sclerosis in Varaždin Region. Neurol Croat 2008, 57(1-2):3-9.
134. Peterlin B, Ristic S, Sepcic J, Vracko BK, Rako A, Lovrecic L, Brajenovic-Milic B, Rudez J, Materljan E, Kapovic M. Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia. J Neurol Sci 2006, 247(2):169-172. 10.1016/j.jns.2006.04.002, 16806273.
135. Klupka-Sarić I, Galić M. Epidemiology of multiple sclerosis in Western Herzegovina and Herzegovina - Neretva Canton, Bosnia and Herzegovina. Coll Antropol 2010, 34(S1):189-193.
136. Klupka-Saric I, Ristic S, Sepcic J, Kapovic M, Peterlin B, Materljan E, Jurisic T, Mamic DM, Burina A, Sulentic V. Epidemiology of multiple sclerosis in western Herzegovina. Clin Neurol Neurosurg 2007, 109(9):779-783. 10.1016/j.clineuro.2007.07.014, 17766036.
137. Milanov I, Georgiev D, Kmetska K, Jordanova L, Topalov N. Prevalence of multiple sclerosis in Bulgaria. Neuroepidemiology 1997, 16:304-307. 10.1159/000109701, 9430130.
138. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M. Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology 2008, 30(3):167-173. 10.1159/000122334, 18382116.
139. Piperidou HN, Heliopoulos IN, Maltezos ES, Milonas IA. Epidemiological Data of Multiple Sclerosis in the Province ofEvros, Greece. Eur Neurol 2003, 49(1):8-12. 10.1159/000067020, 12464712.
140. Gross K, Kokk A, Kaasik A-E. Prevalence of MS in South Estonia. Evidence of a new border of the Fennoscandian Iocus. Acta Neurol Scand 1993, 88:241-246.
141. Koutsouraki E, Costa V, Baloyannis S. Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010, 22(1):2-13. 10.3109/09540261003589216, 20233110.
142. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006, 13(7):700-722. 10.1111/j.1468-1331.2006.01342.x, 16834700.
143. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994, 36(S2):S164-S174. 10.1002/ana.410360803, 7998785.
144. Culpepper W, Ehrmantraut M, Wallin M, Flannery K, Bradham D. Veterans Health Administration multiple sclerosis surveillance registry: the problem of case-finding from administrative databases. J Rehabil Res Dev 2006, 43:17-24. 10.1682/JRRD.2004.09.0122, 16847768.
145. Marrie R, Yu N, Blanchard J, Leung S, Elliot L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010, 74:465-471. 10.1212/WNL.0b013e3181cf6ec0, 20071664.
146. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82:1132-1141. 10.1136/jnnp.2011.240432, 21478203.
147. Esbjerg S, Keiding N, Koch-Henriksen N. Reporting delay and corrected incidence of multiple sclerosis. Stat Med 1999, 18(13):1691-1706. 10.1002/(SICI)1097-0258(19990715)18:13<1691::AID-SIM160>3.0.CO;2-D, 10407238.
148. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Changes in the ascertainment of multiple sclerosis. Neurology 2005, 65(7):1066-1070. 10.1212/01.wnl.0000178891.20579.64, 16217060.
149. Kingwell E, Leung AL, Roger E, Duquette P, Rieckmann P, Tremlett H, The MS. Clinic Neurologists: Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts. J Neurol Sci 2010, 292:57-62. 10.1016/j.jns.2010.02.007, 20202651.
150. Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, Cazzato G, Zorzon M. The use of standardized incidence and prevalence rates in epidemiological studies in multiple sclerosis: a meta-analysis study. Neuroepidemiology 2003, 22:65-74. 10.1159/000067107, 12566956.